Investigating how Immulina can boost the immune system against influenza infections
Examining the Effects of Immulina to Increase Immune Resilience against Influenza Virus Infections
This study is looking at whether a supplement made from Spirulina, called ImmulinaTM, can help boost your immune system to better fight off the flu and other respiratory viruses, and it involves both animals and people to see how well it works.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Mississippi NIH-funded |
| Lab location | 1 site (University, United States) |
| Project ID | NIH-10897156 on NIH RePORTER |
What this research studies
This research focuses on the potential benefits of a Spirulina-based product called ImmulinaTM in enhancing the immune response to influenza and other respiratory viruses. The study will involve both animal models and human participants, assessing how ImmulinaTM supplementation may improve immune resilience. Researchers will measure various immune responses, including the activity of natural killer cells and specific antibodies against the influenza virus. The goal is to determine if this dietary supplement can help individuals better resist or recover from influenza infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at risk for influenza infections, such as those with weakened immune systems or chronic health conditions.
Not a fit: Patients who are not at risk for influenza or those who have contraindications to Spirulina-based supplements may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new dietary strategies for improving immune health and reducing the impact of influenza infections.
How similar studies have performed: Previous research has shown promising results with similar dietary supplements in enhancing immune responses, suggesting potential for success in this study.
Where this research is happening
University, United States
- University of Mississippi — University, United States (Active)
Researchers
- Principal investigator: Marshall, Gailen D. — University of Mississippi
- Study coordinator: Marshall, Gailen D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.